Prognostic value of neutrophil-to-lymphocyte ratio in end-stage liver disease: A meta-analysis

doi:10.4254/wjh.v16.i3.477

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1764)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

907

Figures (1-2)

161

Tables (1-2)

153

Sum=1277

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

352

Sum=421

Mar 27, 2024 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Hepatol. Mar 27, 2024; 16(3): 477-489
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.477

Full Size Figure Download Figure

Figure 1 PRISMA flowchart outlining the study search. NLR: Neutrophil-to-lymphocyte ratio; ESLD: End-stage liver disease.

Citation: Cai XH, Tang YM, Chen SR, Pang JH, Chong YT, Cao H, Li XH. Prognostic value of neutrophil-to-lymphocyte ratio in end-stage liver disease: A meta-analysis. World J Hepatol 2024; 16(3): 477-489
URL: https://www.wjgnet.com/1948-5182/full/v16/i3/477.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i3.477